GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Nanalysis Scientific Corp (TSXV:NSCI) » Definitions » Capex-to-Revenue

Nanalysis Scientific (TSXV:NSCI) Capex-to-Revenue : 0.04 (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Nanalysis Scientific Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Nanalysis Scientific's Capital Expenditure for the three months ended in Sep. 2024 was C$-0.43 Mil. Its Revenue for the three months ended in Sep. 2024 was C$10.57 Mil.

Hence, Nanalysis Scientific's Capex-to-Revenue for the three months ended in Sep. 2024 was 0.04.


Nanalysis Scientific Capex-to-Revenue Historical Data

The historical data trend for Nanalysis Scientific's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanalysis Scientific Capex-to-Revenue Chart

Nanalysis Scientific Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial 0.38 0.37 0.19 0.29 0.16

Nanalysis Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.09 0.05 0.04 0.04

Competitive Comparison of Nanalysis Scientific's Capex-to-Revenue

For the Scientific & Technical Instruments subindustry, Nanalysis Scientific's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanalysis Scientific's Capex-to-Revenue Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Nanalysis Scientific's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nanalysis Scientific's Capex-to-Revenue falls into.



Nanalysis Scientific Capex-to-Revenue Calculation

Nanalysis Scientific's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-4.592) / 28.466
=0.16

Nanalysis Scientific's Capex-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.43) / 10.57
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanalysis Scientific  (TSXV:NSCI) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Nanalysis Scientific Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nanalysis Scientific's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanalysis Scientific Business Description

Traded in Other Exchanges
Address
Bay 105, 90 Freeport Blvd. NE, Calgary, AB, CAN, T3J 5J9
Nanalysis Scientific Corp designs, manufactures and sells a range of nuclear magnetic resonance (NMR) technologies that go into a range of NMR spectrometers and magnetic resonance imaging (MRI) equipment. The company's original product, the 60 MHz MR spectrometer, was the first full-featured benchtop NMR spectrometer available on the market. The Company's activities are carried out through three operating segments, within which are two reportable segments which include Scientific Equipment which includes sales of proprietary and third-party products and Security Services involves maintenance and installation of security equipment. Geographic segments of the group are the U.S., Europe, Canada, Asia, and Other regions.
Executives
Sean Edward Krakiwsky Director, Senior Officer
Guido Cloetens Director
Michal Okoniewski Director
Werner Gartner Director
Martin Andrew Burian Director
Luke Caplette Senior Officer
Julien Muller Senior Officer
Garett Leskowitz Senior Officer
Mohamed Abousalem Director

Nanalysis Scientific Headlines

No Headlines